Home › Research › Brain tissue and pathology
TDP-43 seeding activity in the olfactory mucosa of patients with amyotrophic lateral sclerosis
Maria Vizziello, Ilaria Linda Dellarole, Arianna Ciullini, Riccardo Pascuzzo, Annalisa Lombardo, Floriana Bellandi, Luigi Celauro, Claudia Battipaglia et al.. Molecular Neurodegeneration, 2025-04-26
Topic: Brain proteins, microglia and lab models
Plain-language summary
TDP-43_SAA was positive in 29/65 patients with sporadic MND, 9/21 patients with genetic MND, 6/17 OND patients and 3/22 controls. Surprisingly, one presymptomatic individual also tested positive. As expected, OM of genetic non-TDP-43-related MND tested negative. Interestingly, fluorescence values from non-MND samples that tested positive were consistently and significantly lower than those obtained with sporadic and genetic MND. Furthermore, among TDP-43-positive samples, the lag phase observed in MND patients was significantly longer than that in non-MND patients. Plasma TDP-43 levels were significantly higher in sporadic MND patients compared to controls and decreased as the disease progressed. Similarly, plasma NfL levels were higher in both sporadic and genetic MND patients and positively correlated with disease progression rate (ΔFS). No significant correlations were detected between TDP-43_SAA findings and the biological, clinical, or neuropsychological parameters considered. The OM of a subset of patients with sporadic MND can trigger seeding activity for TDP-43, as previously observed in genetic MND. Thus, TDP-43_SAA analysis of OM can improve the clinical characterization of ALS across different phenotypes and enhance our understanding of these diseases. Finally, plasma TDP-43 could serve as a potential biomarker for monitoring disease progression. However, further research is needed to confirm and expand these findings.
What this study adds
Evidence grade: Low
The record lists 65 participants. TDP-43 seeding activity was detected in olfactory mucosa from some patients with motor neuron disease, and plasma TDP-43 levels were higher in sporadic MND patients than controls and decreased as disease progressed. The authors state further research is needed, and this is a biomarker study, not a treatment or cure.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Vizziello, M., Dellarole, I. L., Ciullini, A., Pascuzzo, R., Lombardo, A., Bellandi, F., et al. (2025). TDP-43 seeding activity in the olfactory mucosa of patients with amyotrophic lateral sclerosis. Molecular Neurodegeneration. https://doi.org/10.1186/s13024-025-00833-0
Vancouver
Vizziello M, Dellarole IL, Ciullini A, Pascuzzo R, Lombardo A, Bellandi F, et al. TDP-43 seeding activity in the olfactory mucosa of patients with amyotrophic lateral sclerosis. Molecular Neurodegeneration. 2025. doi:10.1186/s13024-025-00833-0. PMID: 40287755.
BibTeX
@article{vizziello2025-40287755,
author = {Vizziello, Maria and Dellarole, Ilaria Linda and Ciullini, Arianna and Pascuzzo, Riccardo and Lombardo, Annalisa and Bellandi, Floriana and Celauro, Luigi and Battipaglia, Claudia and others},
title = {{TDP-43 seeding activity in the olfactory mucosa of patients with amyotrophic lateral sclerosis}},
journal = {Molecular Neurodegeneration},
year = {2025},
doi = {10.1186/s13024-025-00833-0},
pmid = {40287755},
url = {https://doi.org/10.1186/s13024-025-00833-0}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record's author list ends in “et al.”, so not every author is named. Check the citation against the original before you use it.
Key findings
- TDP-43_SAA was positive in 29/65 patients with sporadic MND, 9/21 patients with genetic MND, 6/17 OND patients and 3/22 controls.
- Surprisingly, one presymptomatic individual also tested positive.
- As expected, OM of genetic non-TDP-43-related MND tested negative.
- Interestingly, fluorescence values from non-MND samples that tested positive were consistently and significantly lower than those obtained with sporadic and genetic MND.
- Furthermore, among TDP-43-positive samples, the lag phase observed in MND patients was significantly longer than that in non-MND patients.
Why it matters
TDP-43 seeding activity was detected in olfactory mucosa from some patients with motor neuron disease, and plasma TDP-43 levels were higher in sporadic MND patients than controls and decreased as disease progressed. The authors state further research is needed, and this is a biomarker study, not a treatment or cure.
Study details
- Participants65
- Evidence strengthLow
How this study scored 46/100
Published in a peer-reviewed journal. Scored zero for study design, effect reported and randomized / blinded because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Molecular Neurodegeneration) |
| Journal's citation record | 2 / 4 | Molecular Neurodegeneration: journal h-index 164 (OpenAlex, 2026-10-29) |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 1 / 5 | Rated “low” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 4 / 5 | 2025 — within 3 year(s) of the newest study here |
| Sample size | 1 / 4 | 65 participants |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 3 / 3 | Studied in people (participant count stated) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 2 / 7 | Cited 13 times (OpenAlex, 2026-10-10) |
| Citations per year | 2 / 5 | 4.3 citations a year over 3 year(s) since 2025 |
| Impact for its field and year | 3 / 6 | Cited 7.3× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 1 / 6 | Cited by 1 other studies in this library |
| Still being cited | 1 / 4 | Cited 13 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 2 / 4 | Last-listed author Fabio Moda: h-index 34 (OpenAlex, whole career) |
| Institution's track record | 1 / 3 | University of Milan: institution h-index 1,023 (OpenAlex) |
| Multicenter collaboration | 2 / 3 | OpenAlex lists 5 institution(s) in 1 country |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 40287755) |
| Free to read | 2 / 2 | Free to read |
| Total | 46 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
- DOI: 10.1186/s13024-025-00833-0
- PubMed: 40287755
- Original source →
- Free full text: Molecular Neurodegeneration →
Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).
Related
Studies in the library that share something with this one. The line above each title says what.
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here. Showing 12 of 18.
Later studies that cite this one
1 study in the alzhub library lists this one in its references.
Related studies in Brain tissue and pathology from nearby years
Also tagged “tdp-43”
1,150 studies in the library carry the topic tag “tdp-43”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 1,150 tagged studies.